CFDA Logo Image of a U. S. flag

93.770 MEDICARE_PRESCRIPTION DRUG COVERAGE

(Medicare Part D)

FEDERAL AGENCY
CENTERS FOR MEDICARE AND MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES

AUTHORIZATION
Authorized under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, Public Law 108-173, as Section 1860D of the Social Security Act.

OBJECTIVES
To provide prescription drugs to Medicare beneficiaries through their voluntary participation in prescription drug plans, with an additional subsidy provided to lower-income beneficiaries.

TYPES OF ASSISTANCE
Direct Payments for Specified Use.

USES AND USE RESTRICTIONS
Payments will be made to participating prescription drug plans.

Applicant Eligibility
A non-governmental entity organized and licensed under State law as a risk-bearing entity eligible to offer health insurance in each State in which it is to offer a plan, meeting the requirements in 42 CFR 423.504 and 42 CFR 423.505.

Beneficiary Eligibility
Individuals who are entitled to Medicare benefits under Part A or enrolled in Part B, who reside in the plan's service area, and who are not enrolled in a Medicare Advantage plan, other than a Medicare savings account plan or private fee-for-service plan that does not provide qualified prescription drug coverage.

Credentials/Documentation
None.

Preapplication Coordination
This program is excluded from coverage under E.O. 12372.

Application Procedure
Potential sponsors apply to CMS to become an approved prescription drug plan. Generally, individuals enroll directly with the prescription drug program sponsor. The sponsor forwards the enrollment and eligibility information to CMS, which verifies eligibility for the drug benefit. Some individuals who are entitled to both Medicare and Medicaid have been enrolled automatically. Low income beneficiaries may complete a subsidy application at any Social Security office or through their State Medicaid office.

Award Procedure
Payment will be made by CMS to the prescription drug plan sponsors.

Deadlines
Beneficiaries must enroll according to the enrollment periods specified in 42 CFR 423.38. Plans must submit bids by the first Monday in June of the year proceeding the calendar year they wish to participate.

Range of Approval/Disapproval Time
Up to six months for plan sponsors.

Appeals
Sponsors whose applications to become a prescription drug plan sponsor are rejected have the right to a reconsideration and appeal process. Beneficiaries have the right to a reconsideration and appeal process for adverse coverage determinations.

Renewals
Contracts with sponsors may be renewed annually. Beneficiaries may enroll and disenroll from plans according to the timeframes established in 42 CFR 423.30-423.46.

Formula and Matching Requirements
None.

Length and Time Phasing of Assistance
Indefinite.

Reports
Plans must provide periodic reports to CMS, enrollees and the general public on cost; utilization; availability, accessibility and acceptability of services; fiscal soundness and other information required by CMS. Plans must provide an annual report of business transactions and combined financial statements. Also, reports as required under the Employee Retirement Income Security Act of 1974.

Audits
Periodic audits of plans by HHS, the Comptroller General or their designees. Periodic audits by CMS and the HHS Office of Inspector General (OIG) of plan cost reporting. Audit by CMS of financial records of at least one-third of participating plans every year.

Records
None.

Account Identification
75-8308-0-7-571.

Obligations
(Benefit Outlays) FY 07 $49,103,284,000; FY 08 est $45,087,000,000; and FY 09 est $54,815,000,000.

Range and Average of Financial Assistance
Determined by plan offerings,number of enrollees and utilization.

PROGRAM ACCOMPLISHMENTS
As of January 30, 2007, approximately 39 million enrollees had comprehensive drug coverage.

REGULATIONS, GUIDELINES, AND LITERATURE
Regulations governing this program were authorized under Section 1860D of the Social Security Act, as enacted under Public Law 108-173, and were published on January 21, 2005.

Regional or Local Office
None.

Headquarters Office
Program Contacts: Eligibility and enrollment: Lynn Orlosky, Centers for Medicare and Medicaid Services, Department of Health and Human Services, 7500 Security Boulevard, Baltimore, MD 21244-1850. Telephone: (410) 786-9064. Benefits and beneficiary protections: Vanessa Duran, Centers for Medicare and Medicaid Services, Department of Health and Human Services, 7500 Security Boulevard, Baltimore, MD 21244-1850. Telephone: (214) 767-6435. Plan bidding process: Mark Newsom, Centers for Medicare and Medicaid Services, Department of Health and Human Services, 7500 Security Boulevard, Baltimore, MD 21244-1850. Telephone: (410) 786-3198.

Web Site Address
http://www.cms.hhs.gov

RELATED PROGRAMS
93.773, Medicare_Hospital Insurance; 93.774, Medicare_Supplementary Medical Insurance; 93.778, Medical Assistance Program.

EXAMPLES OF FUNDED PROJECTS
None.

CRITERIA FOR SELECTING PROPOSALS
None.


General Services Administration
Office of Chief Acquisition Officer
Regulatory and Federal Assistance Division (VIR)